Financial statements Neuca Clinical Trials Investments
Balance sheet of Neuca Clinical Trials Investments
Company age:
Age:
25 y. 1 m. 18 d.
Share capital:
Share capital:
4 960 000 PLN
Balance sheet data of NEUCA CLINICAL TRIALS INVESTMENTS
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 88 139 107,76 | 87 643 554,39 | 87 634 398,10 | 91 124 617,29 | 89 540 735,20 |
| A. Fixed assets | 74 002 828,08 | 74 002 828,08 | 74 002 828,08 | 74 002 828,08 | 74 002 828,08 |
| B. Current assets | 14 136 279,68 | 13 640 726,31 | 13 631 570,02 | 17 121 789,21 | 15 537 907,12 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 88 139 107,76 | 87 643 554,39 | 87 634 398,10 | 91 124 617,29 | 89 540 735,20 |
| A. Equity | 87 937 962,15 | 87 632 481,20 | 87 614 071,78 | 91 072 196,73 | 89 497 768,13 |
| B. Liabilities and provisions for liabilities | 201 145,61 | 11 073,19 | 20 326,32 | 52 420,56 | 42 967,07 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 196 084,61 | 4 143,19 | 8 924,32 | 28 051,56 | 23 612,07 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD